US FDA accepts Galderma’s RelabotulinumtoxinA BLA resubmission for temporary improvement of moderate-to-severe glabellar lines and lateral canthal lines: Zug, Switzerland Tuesda ...
Alvotech inks supply and commercialization pacts with Sandoz covering multiple biosimilar candidates in Canada, Australia & New Zealand: Reykjavik, Iceland Tuesday, February 3, 20 ...
X-CIPLOG 2026 Reunion celebrates pharma excellence, honours icons from society: Shardul Nautiyal, Mumbai Tuesday, February 3, 2026, 14:15 Hrs [IST] Continuing its legacy of ce ...
Ministry of commerce imposes Minimum Import Price for three APIs: Our Bureau, New Delhi Tuesday, February 3, 2026, 14:30 Hrs [IST] The Union ministry of commerce and industry has ...
US FDA launches PreCheck pilot programme to strengthen domestic pharmaceutical manufacturing: Silver Spring, Maryland Tuesday, February 3, 2026, 14:00 Hrs [IST] The US Food and Dr ...
Sanofi’s LEAP2MONO phase 3 study of venglustat to treat type 3 Gaucher disease meets all primary endpoints: Paris Tuesday, February 3, 2026, 13:00 Hrs [IST] Positive results fro ...
AIOCD hails budget 2026-27 as a visionary roadmap for patient welfare and pharma innovation: Our Bureau, Chennai Tuesday, February 3, 2026, 12:15 Hrs [IST] The All India Organizat ...
International Health Dialogue (IHD) 2026 presented by the Apollo Group on January 30 and 31 2026 at Hyderabad focused on strengthening standards and accountability. It highlighted on how the world ...
EU recommends approval of AstraZeneca’s Imfinzi perioperative regimen for patients with early gastric and gastroesophageal cancers ...
Budget 2026 offers robust bio-pharma base to allow Indian pharma cos to access regulated global markets: Namit Joshi: Shardul Nautiyal, Mumbai Tuesday, February 3, 2026, 08:00 Hrs ...